Drug developers, digital health technology companies, regulators, researchers, clinicians, patient groups, healthcare payers, and healthcare implementers can use the Conceptual Model to make decisions about using evidence-based digital measures of physical activity (PA) as endpoints in clinical trials or for patient monitoring in clinical care.